223 related articles for article (PubMed ID: 20692322)
21. Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice.
Marlatt MW; Lucassen PJ; van Praag H
Brain Res; 2010 Jun; 1341():93-9. PubMed ID: 20381469
[TBL] [Abstract][Full Text] [Related]
22. Central irisin administration affords antidepressant-like effect and modulates neuroplasticity-related genes in the hippocampus and prefrontal cortex of mice.
Siteneski A; Cunha MP; Lieberknecht V; Pazini FL; Gruhn K; Brocardo PS; Rodrigues ALS
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):294-303. PubMed ID: 29524513
[TBL] [Abstract][Full Text] [Related]
23. Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
Yoo SB; Kim BT; Kim JY; Ryu V; Kang DW; Lee JH; Jahng JW
Psychoneuroendocrinology; 2013 Jun; 38(6):777-88. PubMed ID: 23010142
[TBL] [Abstract][Full Text] [Related]
24. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
Pilar-Cuéllar F; Vidal R; Pazos A
Br J Pharmacol; 2012 Feb; 165(4b):1046-57. PubMed ID: 21627639
[TBL] [Abstract][Full Text] [Related]
25. Xiaochaihutang attenuates depressive/anxiety-like behaviors of social isolation-reared mice by regulating monoaminergic system, neurogenesis and BDNF expression.
Ma J; Wang F; Yang J; Dong Y; Su G; Zhang K; Pan X; Ma P; Zhou T; Wu C
J Ethnopharmacol; 2017 Aug; 208():94-104. PubMed ID: 28687505
[TBL] [Abstract][Full Text] [Related]
26. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence.
Rayen I; van den Hove DL; Prickaerts J; Steinbusch HW; Pawluski JL
PLoS One; 2011; 6(9):e24003. PubMed ID: 21912658
[TBL] [Abstract][Full Text] [Related]
27. Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice.
Freitas AE; Machado DG; Budni J; Neis VB; Balen GO; Lopes MW; de Souza LF; Dafre AL; Leal RB; Rodrigues AL
Behav Brain Res; 2013 Jan; 237():176-84. PubMed ID: 23018126
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
Farley S; Dumas S; El Mestikawy S; Giros B
Neuropharmacology; 2012 Jan; 62(1):503-17. PubMed ID: 21945287
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like effect of food-derived pyroglutamyl peptides in mice.
Yamamoto Y; Mizushige T; Mori Y; Shimmura Y; Fukutomi R; Kanamoto R; Ohinata K
Neuropeptides; 2015 Jun; 51():25-9. PubMed ID: 25957094
[TBL] [Abstract][Full Text] [Related]
30. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
31. Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation.
Manosso LM; Moretti M; Ribeiro CM; Gonçalves FM; Leal RB; Rodrigues ALS
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():59-67. PubMed ID: 25600102
[TBL] [Abstract][Full Text] [Related]
32. Fluoxetine prevents the memory deficits and reduction in hippocampal cell proliferation caused by valproic acid.
Welbat JU; Sangrich P; Sirichoat A; Chaisawang P; Chaijaroonkhanarak W; Prachaney P; Pannangrong W; Wigmore P
J Chem Neuroanat; 2016 Dec; 78():112-118. PubMed ID: 27619060
[TBL] [Abstract][Full Text] [Related]
33. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus.
Xu H; Chen Z; He J; Haimanot S; Li X; Dyck L; Li XM
Hippocampus; 2006; 16(6):551-9. PubMed ID: 16652337
[TBL] [Abstract][Full Text] [Related]
34. Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice.
Karpova NN; Lindholm J; Pruunsild P; Timmusk T; Castrén E
Eur Neuropsychopharmacol; 2009 Feb; 19(2):97-108. PubMed ID: 18973993
[TBL] [Abstract][Full Text] [Related]
35. Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment.
Beauquis J; Roig P; Homo-Delarche F; De Nicola A; Saravia F
Eur J Neurosci; 2006 Mar; 23(6):1539-46. PubMed ID: 16553617
[TBL] [Abstract][Full Text] [Related]
36. Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression.
Mendez-David I; Tritschler L; Ali ZE; Damiens MH; Pallardy M; David DJ; Kerdine-Römer S; Gardier AM
Neurosci Lett; 2015 Jun; 597():121-6. PubMed ID: 25916883
[TBL] [Abstract][Full Text] [Related]
37. Fluoxetine treatment ameliorates depression induced by perinatal arsenic exposure via a neurogenic mechanism.
Tyler CR; Solomon BR; Ulibarri AL; Allan AM
Neurotoxicology; 2014 Sep; 44():98-109. PubMed ID: 24952232
[TBL] [Abstract][Full Text] [Related]
38. Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice.
Huang GJ; Bannerman D; Flint J
Mol Psychiatry; 2008 Feb; 13(2):119-21. PubMed ID: 18202694
[No Abstract] [Full Text] [Related]
39. Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway.
Chen Z; Gu J; Lin S; Xu Z; Xu H; Zhao J; Feng P; Tao Y; Chen S; Wang P
J Ethnopharmacol; 2023 Jan; 300():115719. PubMed ID: 36126781
[TBL] [Abstract][Full Text] [Related]
40. Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of selective serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression.
Szopa A; Doboszewska U; Herbet M; Wośko S; Wyska E; Świąder K; Serefko A; Korga A; Wlaź A; Wróbel A; Ostrowska M; Terlecka J; Kanadys A; Poleszak E; Dudka J; Wlaź P
Toxicol Appl Pharmacol; 2017 Dec; 337():95-103. PubMed ID: 29107002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
